BEIJING, May 25, 2010 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company"), a leading China-based biopharmaceutical company focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products, today announced that the Company plans to release first quarter financial results on Wednesday, June 2, 2010, after market close.
The Company will hold a conference call at 8:00 am ET on Thursday, June 3, 2010 to discuss first quarter 2010 results. Listeners may access the call by dialing:
| United States toll free: | 1-866-804-6929 |
| China toll free: | 800-7122655 |
| Hong Kong toll free: | 800-963844 |
| United Kingdom toll free: | 0808-2347616 |
| International: | 1-857-350-1675 |
| Conference ID: | 89012332 |
A telephone replay will be available beginning two hours after the conclusion of the call and will be available through June 10, 2010. Listeners may access the replay by dialing:
| United States toll free: | 1-888-286-8010 |
| International: | 1-617-801-6888 |
| Conference ID: | 85921734 |
A webcast will also be available through the Company's website www.nkbp.com. ;
About China Nuokang Bio-Pharmaceutical Inc.
China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) is a leading biopharmaceutical company in China focused on the research, development, manufacture, marketing and sales of hematological and cardiovascular products. The Company provides a diversified portfolio of products across more than 2,400 hospitals in China. Nuokang's principal products include Baquting®, China's leading hemocoagulase product by market share, and Aiduo®, a cardiovascular stress imaging agent. The Company's product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention. Please visit www.nkbp.com for more information.